| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 06/14/2023 | Seer, Inc. | SEER | Grant | Stock Option (right to buy) | 34.7k | $4.33 | $150.4k | | 06/14/2023 |
| 06/14/2023 | Seer, Inc. | SEER | Grant | Class A Common Stock | 23.4k | $0.00 | $0 | | 06/14/2023 |
| 06/08/2023 | Caribou Biosciences, Inc. | CRBU | Exercise | Option to purchase Common Stock | 10k | $2.96 | $29.6k | | 06/08/2023 |
| 03/20/2023 | Caribou Biosciences, Inc. | CRBU | Exercise | Option to purchase Common Stock | 10k | $2.96 | $29.6k | | 03/20/2023 |
| 02/21/2023 | Caribou Biosciences, Inc. | CRBU | Grant | Option to purchase Common Stock | 510.5k | $6.12 | $3.1M | | 02/21/2023 |
| 06/15/2022 | Seer, Inc. | SEER | Grant | Stock Option (right to buy) | 17.9k | $7.33 | $131k | | 06/15/2022 |
| 06/15/2022 | Seer, Inc. | SEER | Grant | Class A Common Stock | 6k | $0.00 | $0 | | 06/15/2022 |
| 05/09/2022 | Caribou Biosciences, Inc. | CRBU | Exercise | Option to purchase Common Stock | 10k | $0.00 | $0 | | 05/09/2022 |
| 05/09/2022 | Caribou Biosciences, Inc. | CRBU | Exercise | Common Stock | 10k | $2.96 | $29.6k | | 05/09/2022 |
| 01/26/2022 | Caribou Biosciences, Inc. | CRBU | Exercise | Option to purchase Common Stock | 10k | $0.00 | $0 | | 01/26/2022 |
| 01/26/2022 | Caribou Biosciences, Inc. | CRBU | Exercise | Common Stock | 10k | $2.96 | $29.6k | | 01/26/2022 |
| 01/26/2022 | Caribou Biosciences, Inc. | CRBU | Exercise | Common Stock | 10k | $2.96 | $29.6k | | 01/26/2022 |
| 01/26/2022 | Caribou Biosciences, Inc. | CRBU | Exercise | Option to purchase Common Stock | 10k | $0.00 | $0 | | 01/26/2022 |
| 12/20/2021 | Caribou Biosciences, Inc. | CRBU | Grant | Option to purchase Common Stock | 411k | $15.16 | $6.2M | | 12/20/2021 |
| 11/09/2021 | Seer, Inc. | SEER | Grant | Stock Option (right to buy) | 30k | $35.25 | $1.1M | | 11/09/2021 |
| 05/11/2016 | Intellia Therapeutics, Inc. | NTLA | Conversion | Common Stock | 174.8k | $0.00 | $0 | See Footnote | 05/11/2016 |
| 05/11/2016 | Intellia Therapeutics, Inc. | NTLA | Conversion | Common Stock | 5.2M | $0.00 | $0 | See Footnote | 05/11/2016 |
| 05/11/2016 | Intellia Therapeutics, Inc. | NTLA | Conversion | Founder Stock | 270.4k | $0.00 | $0 | See Footnote | 05/11/2016 |
| 05/11/2016 | Intellia Therapeutics, Inc. | NTLA | Conversion | Junior Preferred Stock | 8.1M | $0.00 | $0 | See Footnote | 05/11/2016 |
| 05/05/2016 | Intellia Therapeutics, Inc. | NTLA | Grant | Stock Option (right to buy) | 23.5k | $18.00 | $423.5k | | 05/05/2016 |